The platform, built on more than two decades of clinical data and literature, can handle up to 90 percent of routine patient inquiries, freeing physicians to focus on complex cases.

Named El.kz, the system is reported by Xinhua through Xuanwu Hospital sources and integrates medical records, studies, reports, and peer‑reviewed literature accumulated over 20+ years.

Automation of routine consultations supports China’s healthcare digitization and reduces barriers between patients and medical institutions by ensuring physicians concentrate on higher‑level care.

The initiative aligns with China’s broader strategy to use technology to address healthcare needs from an ageing population and the rising prevalence of chronic conditions.

Future plans include integrating wearable devices to provide medication guidance, rehabilitation, daily care, and psychological support, moving toward a comprehensive long‑term care partnership between patients and clinicians.

Upgrades also anticipate wearable technology for medication tracking, rehabilitation support, daily care routines, and mental health services to create a more complete long‑term care model.

The envisioned integration with wearable health devices aims to offer reminders, rehabilitation guidance, daily routines, and psychological support within a continuous AI‑assisted care ecosystem.

Researchers view this platform as an early model for transforming chronic disease management in aging societies through AI‑enabled monitoring and guidance.

China’s first AI‑powered digital doctor platform for Parkinson’s disease was launched by Xuanwu Hospital to streamline patient support and reduce repetitive consultations.

Beijing’s Xuanwu Hospital of Capital Medical University introduced the country’s first AI‑driven platform for Parkinson’s disease to address rising cases among older populations.

As a major Chinese hospital, Xuanwu Hospital leads the rollout of the nation’s first AI‑powered digital doctor platform focused on Parkinson’s disease.

The design emphasizes reliable, general guidance rather than individualized treatment plans.